Allergy and immunology


Basic research

Cardiovascular medicine

Complementary medicine and alternative therapies

Critical care / intensive care

Dentistry / oral medicine


Emergency medicine




Evidence-based medicine



Geriatric medicine / aging

Haematology / blood transfusion

Health economics

Health policy

History of medicine

Infectious diseases

Internal medicine

Laboratory medicine

Medical education

Medical informatics



Nutrition and metabolism

Obstetrics and gynaecology

Occupational and environmental medicine



Organisation of health care

Otolaryngology / head and neck surgery


Palliative care


Patient-physician relationship

Pharmacology and therapeutics

Primary care, family medicine

Psychiatry and psychotherapy


Public health

Quality of care


Rehabilitation medicine

Renal medicine

Respiratory medicine


Sexual medicine

Sports medicine

Statistics and research methods



Travel medicine


Ops! No article found. Reset filter

Deficiencies in paediatric research applications delaying ethics committee approval

Original article
Bergstraesser E, Nadal D, Özgü H, Kleist P
Swiss Med Wkly. 2020;150:w20267

Careful preparation of submission documents by the investigators and close adherence to formal and legal requirements have the potential to considerably optimise and expedite the ethics committee review process, and thus the commencement of the clinical research.

One in seven Swiss physicians has left patient care - results from a national cohort study from 1980-2009

Original article
Streit S, da Costa BR, Christensen S, Tal K, Tandjung R, Jüni P
Swiss Med Wkly. 2019;149:w20116

Physician shortage is problematic, but the percentage of physicians who have left patient care in Switzerland is unclear.

Diagnostic diversity – an indicator of institutional and regional healthcare quality

Original article
Brutsche M, Rassouli F, Gallion H, Kalra S, Roger VL, Baty F
Swiss Med Wkly. 2018;148:w14691

The diagnostic diversity index can be seen as an indicator of diagnostic precision - the higher the degree of diversity, the better the diagnostic precision.

Rationale and methods of an observational study to support the design of a nationwide surgical registry: the MIDAS study

Original article
Vach W, Saxer F, Holsgaard-Larsen A, Overgaard S, Farin-Glattacker E, Bless N, Bucher HC, Jakob M
Swiss Med Wkly. 2018;148:w14680

Surgical registries are becoming increasingly popular, and Swiss legislation requires data on therapeutic outcome quality. The Swiss Association of Surgeons has agreed on a first minimum data set for a nationwide registry.

A digitally facilitated citizen-science driven approach accelerates participant recruitment and increases study population diversity

Original article
Puhan MA, Steinemann N, Kamm CP, Müller S, Kuhle J, Kurmann R, Calabrese P, Kesselring J, von Wyl V, Swiss Multiple Sclerosis Registry (SMSR)
Swiss Med Wkly. 2018;148:w14623

Conventional clinical studies have a number of shortcomings such as restictive exclusion criteria and failure to address patient-relevant outcomes. Recent developments in society and technology could help to overcome some of these problems.

External validation of the 80+ score and comparison with three clinical scores identifying patients at least 75 years old at risk of unplanned readmission within 30 days after discharge

Original article
Schwab C, Le Moigne A, Fernandez C, Durieux P, Sabatier B, Korb-Savoldelli V
Swiss Med Wkly. 2018;148:w14624

A potentially avoidable readmission is an unplanned readmission occurring within 30 days of discharge. As 20% of hospitalised elderly patients are rehospitalised as an unplanned readmission, it is necessary to identify those at risk.

Insufficient recruitment and premature discontinuation of clinical trials in Switzerland: qualitative study with trialists and other stakeholders

Original article
Briel M, Elger B, von Elm E, Satalkar P
Swiss Med Wkly. 2017;147:w14556

Premature discontinuation occurs in about 25% of randomised clinical trials in Switzerland; it mainly affects investigator-initiated trials and is mostly due to problems with recruitment of patients.

Prevalence of tobacco smoking in Switzerland: do reported numbers underestimate reality?

Original article
Jakob J, Cornuz J, Diethelm P
Swiss Med Wkly. 2017;147:w14437

Could it be that legislators and other public health professional base their tobacco control policy decisions on smoking prevalence estimates that are more reassuring than may be justified?

Estimating the incidence of traumatic spinal cord injuries in Switzerland: Using administrative data to identify potential coverage error in a cohort study

Original article
Chamberlain JD, Ronca E, Brinkhof MW
Swiss Med Wkly. 2017;147:w14430

Administrative data are routinely collected in many high-resource countries and offer a wealth of information related to health, but interpretation of these data must take into account its limitations in terms of incomplete, biased coverage.

When federal science is muffling harm reduction by vaping

Technical comment
Poirson P
Swiss Med Wkly. 2016;146:w14331

Verpassen Sie keinen Artikel!